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[ETTER TO THE EDITOR
nvestigating genetic variation of adrenergic
eceptors in familial stress cardiomyopathy
apical ballooning syndrome)
o the Editor,
In their recently published article, Sharkey et al. [1]
enotyped three adrenergic receptor polymorphisms in a
ohort of 41 patients with stress cardiomyopathy (SC). This
diopathic but reversible disorder, also known as takotsubo
ardiomyopathy and apical ballooning syndrome, typically
ccurs in postmenopausal women, presenting with ischemia-
ike chest pain, transient ECG changes, and minor cardiac
iomarker elevation following acute emotional or physical
tress. Angiography of SC patients demonstrates unob-
tructed coronary arteries, while ventriculography shows
yperkinesis of the basal myocardium and hypokinesis of
he apical and/or mid-ventricular wall extending beyond
he territory of a single coronary artery [2]. Sharkey
t al. investigated functional polymorphisms of B1 and
lpha 2c adrenergic receptors, previously implicated in
ncreased activation of the sympathetic nervous system, but
ound no signiﬁcant differences in polymorphism frequen-
ies between SC patients and controls. However, a genetic
asis for the disorder is suggested by familial cases [3,4], and
fundamental defect in adrenergic signaling remains one of
he most compelling pathogenic hypotheses [5,6], providing
he rationale for our comprehensive mutational analysis of
drenoreceptor genes in a rare case of familial SC [4].
We targeted the genes encoding the B1 (ADRB1),
2 (ADRB2), and alpha 2c (ADRA2C) adrenergic recep-
ors, which harbor functional variants modulating cardiac
esponse to catecholamines. Indeed, Zaroff et al. demon-
trated an association between polymorphisms within these
drenoreceptors and cardiac dysfunction attributed to post-
ubarachnoid hemorrhage (SAH)-induced catecholamine
urge [5]. In particular, the Arg-389 ADRB1 and ADRA2C
el322—325 polymorphisms, linked to enhanced cardiac
atecholamine sensitivity and impaired regulation of nore-
inephrine release, respectively, were independently and
ynergistically associated with cardiac injury. Notably, the
eversible regional left ventricular dysfunction seen in SAH
atients is phenotypically similar to SC.
For our study we included ADRB2, in addition to ADRB1
nd ADRA2C, based on evidence from animal investigations.
igher concentrations of B-adrenoreceptors were found
[
914-5087/$ — see front matter © 2009 Japanese College of Cardiology.
oi:10.1016/j.jjcc.2009.08.008n the apical versus basal myocardium in canine hearts,
ndicating that the apex may be more sensitive to cir-
ulating catecholamines. Furthermore, over-expression of
uman B2-adrenergic receptors in mice subject to supra-
hysiological epinephrine levels had a negative inotropic
ffect on cardiomyocytes. These observations led to the
ypothesis that during times of stress, when epinephrine
s the main circulating catecholamine, regional differences
n epinephrine sensitive B2-receptors could explain the
yocardial response to catecholamine surge seen in SC [6].
hus, we postulated that mutation of ADRB2 could accentu-
te vulnerability of the heart to adrenergic stress.
A genomic DNA sample was obtained from a previously
eported 44-year-old female with familial SC [4], which
ecurred one year later after a second episode of extreme
motional stress. Written informed consent was provided
nder a protocol approved by the Mayo Clinic Institutional
eview Board. To sequence the targeted genes, primer pairs
ere designed for polymerase chain reaction ampliﬁca-
ion of the entire coding regions of the single exon genes
DRB1 (2862 bp), ADRB2 (2033 bp) and ADRA2C (1952 bp).
omozygosity for the more common alleles of established
unctional polymorphisms was found (ADRA2C wt/wt, ADRB1
89 Arg/Arg, ADRB1 49 Ser/Ser). Moreover, comprehensive
NA sequence analysis of these adrenergic receptor genes
evealed no mutations in our familial SC case. While a
olecular defect in adrenergic signaling remains a plausible
athogenic mechanism, our data together with the ﬁndings
f Sharkey et al. indicate that the underpinnings of SC are
ot likely based on genetic variation in adrenergic receptors.
eferences
1] Sharkey S, Maron B, Nelson P, Parpart M, Maron M, Bristow
M. Adrenergic receptor polymorphisms in patients with stress
(tako-tsubo) cardiomyopathy. J Cardiol 2009;53:53—7.
2] Bybee K, Prasad A. Stress-related cardiomyopathy syndromes.
Circulation 2008;118:397—409.
3] Prison L, De Vusser P, Mullens W. Apical ballooning in relatives.
Heart 2004;90:e67.
4] Kumar G, Holmes Jr D, Prasad A. ‘‘Familial’’ apical balloon-
ing syndrome (Takotsubo cardiomyopathy). Int J Cardiol 2009,
doi:10.1016/j.ijcard.2009.03.078.
5] Zaroff J, Ludmila P, Miss J, Yarlagadda S, Ha C, Achrol A, Kwok P,
McCulloch C, Lawton M, Ko N, Smith W, Young W. Adrenoceptor
polymorphisms and the risk of cardiac injury and dysfunction
after subarachnoid hemorrhage. Stroke 2006;37:1680—5.
Published by Elsevier Ireland Ltd. All rights reserved.
Letter to the Editor
[6] Lyon A, Rees P, Prasad S, Poole-Wilson P, Harding S. Stress (Takot-
subo) cardiomyopathy—–a novel pathophysiological hypothesis to
explain catecholamine-induced acute myocardial stunning. Nat
Clin Pract Cardiol 2008;5:22—9.
Adele D. Handy (BS)a
Abhiram Prasad (MD)b
Timothy M. Olson (MD)b,c,∗
a Mayo Medical School, Mayo Clinic, 200 First Street SW,
Rochester, MN, 55905, USA
b Division of Cardiovascular Diseases, Department of
Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN,
55905, USA517
c Division of Pediatric Cardiology, Department of Pediatric
and Adolescent Medicine, Mayo Clinic, 200 First Street SW,
Rochester, MN, 55905, USA
∗Corresponding author at: Cardiovascular Genetics
Laboratory, Stabile 5, Mayo Clinic, 200 First Street SW,
Rochester, MN, 55905, USA.
E-mail address: olson.timothy@mayo.edu
(T.M. Olson)Received: 10 August 2009;
accepted: 26 August 2009
Available online 12 October 2009
